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Depression and Antidepressant Use
among People Living with HIV in Hawaii:
Focus on Native Hawaiians
Abstract
Depression. tncludng antidepressant use hs not been
widely studred n the HlVoosrtive popu!at!on or at all
/n Hl%oosrtive Native Hawaiians, Of 1016 clients in
Ha wa//h H/V Seropositivity and Medical Management
Program in 2001-2002, 300 (30%) reported having
depression and half reported taking antidepressants.
Native Havvaiians had the lowest depression rates
of any group. Antidepressant use did not vary by
race/ethnicity.
Introduction
Depression is canmon symptoni of HIV disease.
with an estiniated pres alence of 22 /—450 Penzak et
a!. 2000L Studies have found an association betseen
depression and negative effects on the health of HIV-.
infected indis iduals. including delays in protease
inhibitor initiation, acceleration in disease progression.
and an increase in the probability ot death Leser—
man 2000. Mavnc ci al. 1996j. Qual it\ of life issues
have also become mncreasinelv important for people
with H IV disease. particularly those on antiretroviral
therapv.Antidepressants offer the promise of easing
the symptoms of depression among H IV—infected
individuals and of possibly lowering total health care
costs (Sambamoorthi et a!. 2000).
This research investigates self-reported depression
and antidepressant use among HIV-positive individuals
in Hawaii during 2001 to 2002. It focuses on the im
portance of race/ethnicity, particularly Native Hawaiian
ethnicity, as ss elI as other factors in explaining self—
reported depression and self—reported antidcpre’s ant
use.
While depression and the use of antidepressants have
been studied in some 1—11 V—positive popul atm m s. most
notabl\ svhite.Atrmcan Americans. and Hispanics.
there are no published studies of Naims e Hawanans.
in addition, previous rcsearc h on depression and
antidepressant use in H I V—positive persons has only
focused on the Medicaid population (see Samiihanioorthi
et al. 200flc Because l’theeconomicall and sociall’
discrsc population used in this studs. it can pros ide
broader insights. I- r example. the research assesses
study outcomes.
Methods
The data source is Hawaii’s HIV Seropositivitv and
Medical Management (HSPAMM) Program. which
contains sociodemographic, behavioral, and medical
data on HIV infected persons throughout the State of
Hawaii. KSPAMM is the largest and most represen
tative source of data on HIV-positive individuals in
Hawaii. I {SPAMM is a statewide program admin
istered by the STD/AIDS Prevention Branch of the
Hawaii Department of Health. Any person residing
in Hawaii ss ho is H V—positive, regardless of income
level, is eligible l’or HSPAMM. The program pays
all costs associated with a standard set of services at
semi—annual ph sician visits. each visit, extensive
information is collected from patient questionnaires.
phssician exammations. and laborator\ testing. ‘l’he
HSPAMM program follows these individuals longi
tudinaHv through the use of a unique identifier client
coding s stem.
Over 2,500 individuals have participated in HS
PAMM since its inception in 1989. Data for this
analysis were obtained for all HSPAMM enrollees
who made at least one HSPAMM visit during 2001
or 2002. If multiple visits were recorded for an
enrollee during the two-year period (which is likely
since HSPAtvIM covers two visits per year). unIv
the first recorded visit for the two—year period ss as
used. During 2001 and 2ff 2, HSPAMM had 1 .016
enrol lees.
The SAS S\ stem version 8.2 was used for all sta
tistical anaL ses. Logistic regression was applied to
the data to identif the variables associated ss ith de
pression and antidepressant use among HIV-inl’eeted
individuals in the HSPAMM program. Lisingstepss ise
selection, all ‘ armables with a p—s’alue of less than ((.3(1
wei’e remus ed h’om successive models until the iuost
parsimonious model was found for each dependent
variable. Adjusted odds ratios OR) and associated
confidence intervals were calculated from parimeter
the importance of income and health insurance on
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estimate transformations. Odds ratios that exceed I
indicate an increased likelihood (statistical significance
of p<(.05) of self-reported depression or self-reported
use of antidepressant medication, respectively.
Both of the dependent variables are dichoto
mous, The first dependent variable is self-reported
depression. Depression is defined as self-reported
depression lasting at least two months, self-reported
hospitalization for depression during the past six
months, or self-reported antidepressant use during the
past six months. The second dependent variable is
self-reported antidepressant use Antidepressant use
is defined as self-reported antidepressant use during
the past six months.
Data for the independent variables were self-re
ported (gender. race/ethnicity, born in Hawaii, age,
income, medical insurance, antiretroviral use, smoke
cigarettes. drink alcohol, use marijuana, and use hard
drugs). or obtained from laboratory data (likelihood
of developing an AIDS-related illness within three
years). Hard drugs were defined as cocaine, heroin
and/or methamphetamines. Likelihood of developing
an AIDS-related illness is apatient severity index that
combines both the patient’s CD4+T lymphocyte count
and RT-PCR HIV plasma viral load, and estimates the
likelihood that a patient will develop an AIDS-related
illness within three years (Panel on Clinical Practices
fbr Treatment of WV Infection, 2001). The three
categories are: less than I % likelihood of develop
ing an AIDS-related illness, 2%-16% likelihood of
developing an AIDS-related illness, and greater than
32% likelihood of developing anAIDS-related illness
within three years. All independent variables were
dichotomous except race/ethnicity and likelihood of
developing an AIDS-related illness.
Results
Table I presents the sociodemographic. medical, and
alcohol and drug use characteristics for the entire
stud population, for the subset with self-reported
depression. and for the subset on antidepressant medi
cation. There were 1.016 HIV-infected persons in
the study population and 300(30%) had self-reported
depression. Of the 300 individuals with self reported
depression, 146(49%) reported taking antidepressant
medication.
For the entire study population. females comprised
11% and males 89%. Asians accounted for 12%.
Native Hawai ians or Part Native Hawaiians 14%,
Hispanics 7%, whites 58%. and other races and ciii
nicities 9%, In the study population, 75% was not
born in Hawaii and 61% was 40 years of age or older.
Approximately 39% had income less than S I (),000
per year. and only 1 3% had no medical insurance
coverage. Over two-thirds of clients (70%) were on
antiretroviral drugs and less than one-quarterof clients
(22%) cit. in thL most su Lrcl ill of thc thi U. patient
Table I — Characteristic at Study Papulatioi and Analytic Subse
HSPAMM S m SeltReported SeltReporteda P e Depression Antidepressant Use
Number Percent Number Percent Number Percent
N 1,016 100% 30Cr 100% 146r 100%
Gender
Female 113 11 34 11 16 11
Male 897 89 265 89 129 89
Ethnicity
Asian 119 12 28 10 7 5
Native Hawaiian 139 14 25 8 12 8
Hispanic 73 7 25 8 10 7
Other 96 9 32 11 12 8
White —_582 58 188 63 104 72
Born in Hawaii
Yes 256 25 61 21 20 14
No 750 75 235 79 123 86
Age
400rmoreyears 615 61 182 61 102 71
Less than 40 years 393 39 116 39 42 29
Income
$10,000 or more/year 597 61 155 53 95 66
Less than $10000/year 385 39 136 47 48 34
Medical Insurance
Yes 873 87 257 86 137 94
No 132 13 42 14 9 6
AIDS Illness Likelihood
>32% 214 22 68 24 26 19
2% to 16% 222 24 63 23 22 16
<1% 525 54 149 53 87 65
Antiretroviral Use
Yes 714 70 210 70 124 85
No 302 30 90 30 22 15
Smoke Cigarettes
Yes 402 40 140 47 62 43
No 607 60 158 53 83 57
Drink Alcohol
Yes 432 43 115 39 57 39
No 570 57 182 61 88 61
Use Marijuana
Yes 510 50 174 58 79 54
No 501 50 124 42 67 46
Use Hard Drugs
Yes 188 19 66 22 24 16
No 822 61 231 78 122 84
= Variable totals may not add up to 1.016 or 300 or 146, respectively. oue to missing values
severity of illness categories. Fewer than half of all clients used alcohol or any
specific drug, except for marijuana, which was used by 50% of all clients,
Table 2 presents adjusted odds ratios and associated confidence intervals for
self-reported depression among clients in the entire study population. HIV-infected
Native Hawaiians in the HSPAMM program were significantly less likely to have
self-reported depression than whites (OR=0.42, 95% Cl t).25-0.7 1). While Asians
also were less likely than whites to have self-reported depression. the difference
was not statistically significant tOR=0.62. 95% Cl 0.37-1 .02t.
Three other variables in the model were also found to have an effect on self-
reported depression in the study population. First, individuals who smoked
cigarettes were more likely to have self-reported depression (OR=l.6l, 9Sf-
CI 1 .18—2.20). Second, individuals who drank alcohol were less likely to have
>clt icportcd dprLssIon (OR=0 68 95% CI 049 093) Thud those w.ho usud
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Table 2— Adjusted Odo Ratios for Depression and At depressant Use
Logistic Regression Logistic Regression
for Self-Reported for Self-Reported
Depression Antidepressant Use
OR 95%Cl OR 95%Cl
N
Gender
Female
Male
Ethnicity
Asian 0.62 [0.37-1.02]
Native Hawaiian 0.42* [0.25-0.71]
Hispanic 0.98 [0.55-1.75]
Other 1.09 [0.65-1.80]
White Ret Ref
Born in Hawaii
Yes 0.67 [0.33-1.35]
No Ret Ref
Age
40 or more years 1.67 [0.94-2,98]
Less than 40 years Ret Ret
Income
$10,000 or more/year 0.75 [0.55-1.03] 2,06* [1.1 6-3.67]
Less than $1 0000/year Ret Ret Ret Ref
Medical Insurance
Yes 2.21 [0.90-5.44]
No Ret Ret
AIDS Illness Likelihood
>32% 0.73 [0.36-1.45]
2%to 16% 0.53 [0.26-1.09]
<1% Ret Ret
Antiretroviral Use
Yes 1.19 [0.86-1.66] 3.03’ [1.55-5.91]
No Ret Ret Ret Ret
Smoke Cigarettes
Yes 1,61* [1.18-2,20] 1.53 [0.85-2.77]
No Ret Ret Ret Ret
Drink Alcohol
Yes 0.68* [0.49-0.93]
No Ref Ret
Use Marijuana
Yes 1,39* [1.01-1.90]
No Ret Ret
Use Hard Drugs
Yes 0.64 [0.31-1.32]
No Ret Ret
*
= 95% confidence interval does not include 1.0
marijuana were more likely to have self-reported depression (OR=l.39, 95ff Ci
1.01-I .90).
Table 2 presents adjusted odds ratios and assocmted contIdence intervals for
self-reported antidepressant use among members of the study population with
self-reported depression. The final logistic regression model created through
stepwise selection did not include the race/ethnicity variable, Thus, race/ethnic
ity. including Native Hawaiian ethnicity, is not considered to he an important
determinant in whether an HIV-infected individual with self-reported depression
is on antidepressant medication.
The logistic regression model did identify two variables of significance for
antidepressant use in this population. Depressed individuals with an income
of $ 10,000 or more per year were more likely to he treated with antidepressant
medication (OR=2.06. 95% Cl 1.16-3.67). Also.
depressed persons on antiretroviral therapy were more
likely to take antidepressant medication (OR=3.03,
95% Cl 1.55-5.91).
Discussion
The prevalence of depression among HSPAMM
enrollees—30 percent—is similar to other studies
of depression in HIV-positive individuals (Penzak
et al. 20)0), However, since this group may include
some individuals who do not have clinical depres
sion, the actual prevalence of clinical depression in
this population is probably lower. The proportion of
depressed HSPAMM clients on antidepressants—49
percent—is similar to that cited in another published
study (Sambamoorthi et al. 200€]).
The analysis shows important differences between
racial/ethnic groups in self-reported depression. Na
tive Hawaiians had significantly lower adjusted rates
of depression than whites and the lowest rates of any
racial/ethnic group in the study. Asians also had lower
adjusted rates of depression than whites, but the rates
were not statistically significant.
These results raise interesting questions. Why do
Native Hawaiians have the lowest depression rates
of any racial/ethnic group? is it due to cultural rea
sons, family support in Hawaii, support networks in
Hawaii. genetic factors, coping strategies? Further
studies investigating these questions might provide
valuable insight into depression among HIV-positive
people in Hawaii and allow for the development of
better treatment and coping strategies not only for Na
tive Hawaiians with H1V. but also ft)r other affected
racial/ethnic groups.
The study found that persons using tobacco were
significantly more likely than non-users to have
self reported depression. The higher likelihood of
depression among tobacco smokers and marijuana
users may be a result of depressed individuals treat
ing their depression through tobacco or marijuana
use. Conversely, alcohol drinkers were significantly
less likely than non-drinkers to have self-reported
depression. These findings appear counterintuitive.
as one might expect drinkers to have higher rates of
depression. The explanation may bean artefactual one.
as this variable does not separate social drinking from
alcohol abuse. Individuals who drink in moderation
may find alcohol to he a way to relax and cope with
stress, instead of creating or deepening depression as
can he the case in alcohol abuse,
The study found no significant differences in an
tidepressant use by race/ethnicity. This finding is a
positive result of the study. It suggests that there are
not race-related differences in access to antidepressant
medication for HSPAMM clients with self-reported
depression.
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While antidepressant use was not associated with race/ethnicit.
it was associated with takine antirctroiral medication. Since the
study results do not indicate that taking antiretro iral medication
predisposes one to depression. they may suggest that taking medi
cation br HIV increases the vi lingncss of an individual to take
antidepressant medication for their depression.
Antidepressant use was income sensiti\ e. Individuals with incomes
greater than S10.0(tO per ear were more llkel\ to he treated with
anttdepressants. These results indicate that. in spite of the gencr—
Otis cligihilit requirements and henetits as ailahle through its HIV
Drug Assistance Program Li DAP). income is still a key factor in
determining whether an HR-positive individual receives needed
medication in Hawaii. More research is needed into why these bar
riers exist and how to improve access to appropriate medications
for Hawaii’s HR—positive poor population.
A critical issue raised by this research is why only half of HIV
infected persons ss ith self-reported depression are taking anOde
pressants. While some HSPAMM patients reporting depressive
symptoms may not have clinical depression and some may be
treating their depression through non-pharmacological means (e.g..
psychotherapy), it is likely that many patients who could be helped
through antidepressants are not being treated. Some physicians may
consider depressed mood to be a normal state in patients with FIIV
disease, They may attn hute fatigue, sleeping problems. or loss of
appetite solely to HIV or medication side effects and not recognize
the full effects that depression may be having on functioning (Sam
bamoorthi et al. 2000). Some patients may not want to add another
drug to a complex medication regimen or accept side effects further
limiting their functioning ( Sambamoorthi et al. 2000). Physicians
should work with patients to properly treat depressive symptoms
as many antidepressant medications bring rapid clinical response,
are easily tolerated, and can he used during the latest stages of HIV
disease Sambantoorthi et al. 2000). Further, depression may he
influencing somatic symptoms and antidepressant treatment can
produce impro ement in these s\ niptoms Sambamoorthi et al.
2000.
The s1ud had sonic important limitations. First. while retlective
of the HIV epidemic in Flaw au. O\ er half of the sample was coin—
prised of whites: sample sties for other racial/ethnic groups were
much smaller. Second, because most of the data was self—reported
by respondents and collected by the KSPAMM program through
an anonymous data collection process. the reliahilitn and validit
of these data coLild not be veritied. Third. the individuals enrolled
in HSPAM\l are likely less disenfranchised individuals. These
are individuals with a primary care provitler. Individuals who aie
not receis ing care for their HR infection or are receiving it in a
haphazard ss a tend not to enroll m the lISPAMM program.
This research piusvidesevidcucc that ative Hawauans lis uig with
HIV hase a lower prevalence ot depression than other racial/ethnic
groups. but not different antidepressant usage patterns. Asians
also has e a low er prevalence of depression than whites, although
the results were not statistically signiticant. Further research into
the reasons for these differences, as well as other questions associ
ated with depression and antidepressant use in the HIV-positive
population in I-law au. could provide important information guiding
the treatment of individuals with HIV infection and improve their
quality of life.
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